检验医学 ›› 2013, Vol. 28 ›› Issue (5): 400-403.DOI: 10.3969/j.issn.1673-8640.2013.05.013

• 临床应用研究.论著 • 上一篇    下一篇

早期类风湿性关节炎患者血清Ⅰ型胶原吡啶交联终肽、基质金属酶-3等指标的检测及意义

董奕裕   

  1. 1.浙江省荣军医院检验科,浙江 嘉兴 314000;2.浙江省荣军医院中西结合骨伤科,浙江 嘉兴 314000;3.浙江省荣军医院放射科,浙江 嘉兴 314000;4.浙江省荣军医院风湿免疫科 ,浙江 嘉兴 314000
  • 收稿日期:2012-12-14 修回日期:2013-03-12 出版日期:2013-05-15 发布日期:2013-05-14
  • 通讯作者: 董奕裕
  • 作者简介:董奕裕,男,1968年生,学士,主管技师,主要从事临床免疫学研究。
  • 基金资助:

    嘉兴市科技局计划项目(2010AY1053)

Detection and significance of serum cross-linked carboxyterminal telopeptide region of type Ⅰ collagen and matrix metalloproteinase enzyme-3 in patients with early rheumatoid arthritis

  1. 1. Department of Clinical Laboratory, Rongjun Hospital of Zhejiang, Zhejiang Jiaxing 314000, China; 2. Department of Integrative Medicine Orthopedics, Rongjun Hospital of Zhejiang, Zhejiang Jiaxing 314000, China; 3. Department of Radiology, Rongjun Hospital of Zhejiang, Zhejiang Jiaxing 314000, China; 4. Department of Rheumatism Immunology, Rongjun Hospital of Zhejiang, Zhejiang Jiaxing 314000, China
  • Received:2012-12-14 Revised:2013-03-12 Online:2013-05-15 Published:2013-05-14

摘要: 目的 探讨Ⅰ型胶原吡啶交联终肽(ICTP)、基质金属酶-3 (MMP-3) 、抗环瓜氨酸肽(CCP)抗体、类风湿因子(RF)检测及类风湿性关节炎(RA)活动度在RA早期诊断中的意义。 方法 应用酶联免疫吸附试验(ELISA)检测213例RA患者(早期RA组92例、中长期RA组121例)、43例非RA的其他免疫系统疾病患者和40名正常对照者血清ICTP、MMP-3及抗CCP抗体;同时采用免疫比浊法检测血清RF。 结果  ICTP、MMP-3、抗-CCP抗体、RF在早期RA诊断中的最佳临界值分别为3.21 μg/L、67.45 ng/mL、15.45 U/mL、12.35 U/mL,灵敏度分别为74.0%、63.4%、52.4%、55.3%,特异性为95.5%、81.8%、95.5%、90.9%。RA各组RF、抗CCP水平均高于对照组及非RA组(P<0.01),ICTP、MMP-3、RF在非RA组和正常对照组间差异有统计学意义(P<0.01),ICTP在早期RA与非RA组间差异无统计学意义(P>0.05)。X线分期中Ⅰ期患者的ICTP、MMP-3、抗CCP抗体及RF水平与Ⅱ、Ⅲ期、Ⅳ期患者比较差异均有统计学意义(P<0.05、P<0.01)。Ⅱ期患者ICTP、MMP-3及抗CCP抗体水平与Ⅲ、Ⅳ期比较差异均有统计学意义(P<0.05、P<0.01),而RF水平3组之间差异无统计学意义 (P>0.05)。 结论 同时检测ICTP、MMP-3、抗CCP抗体和RF能提高RA早期诊断的准确性,减少漏诊,动态联合检测可有效监测RA病情进展。

关键词: Ⅰ型胶原吡啶交联终肽, 基质金属酶-3, 抗环瓜氨酸肽抗体, 类风湿因子, 类风湿性关节炎

Abstract: Objective To investigate the significance of cross-linked carboxyterminal telopeptide region of type Ⅰ collagen (ICTP), matrix metalloproteinase-3 (MMP-3), anti-cyclic citrullinated peptide (CCP) antibody, rheumatoid factor (RF) and rheumatoid arthritis(RA) activity in the early diagnosis of RA.  Methods The enzyme-linked immunosorbent assay(ELISA) was used to determine the serum samples of 213 patients with RA (early RA group: 92 cases and medium-and long-term RA group: 121 cases), 43 patients with non-RA associated and immune diseases and 40 healthy controls. The serum ICTP, MMP-3 and anti-CCP antibody were determined. The serum RF was determined by immunoturbidimetry.  Results The optimal cut-off values of ICTP, MMP-3 and anti-CCP antibody in the diagnosis of early RA were 3.21 μg/L, 67.45 ng/mL, 15.45 U/mL and 12.35 U/mL. The sensitivities were 74.0%,63.4%,52.4% and 55.3%, and the specificities were 95.5%, 81.8%, 95.5% and 90.9%. RF and anti-CCP antibody were higher in the RA group than in the healthy control group and the non-RA group (P<0.01). ICTP, MMP-3 and RF in the non-RA group and the healthy control group had statistical significance ( P<0.01). ICTP in early RA and non-RA  group had no statistical significance (P>0.05). The ICTP, MMP-3, anti-CCP antibody and RF of X ray staging Phase Ⅰ had statistical significances with those staging Phase Ⅱ, Ⅲ and Ⅳ(P<0.05, P<0.01). The ICTP, MMP-3 and anti-CCP antibody of Phase Ⅱ with those of Phase Ⅲ and Ⅳ had statistical significance (P<0.05, P<0.01). The RF among Phase Ⅱ, Ⅲ and Ⅳ had no statistical significance (P>0.05). Conclusions The simultaneous detection of ICTP, MMP-3, anti-CCP antibody and RF can improve accuracy and reduce missed diagnosis. Dynamic combination detection can monitor effectively the progression of RA.

Key words: Cross-linked carboxyterminal telopeptide region of type Ⅰ collagen, Matrix metalloproteinase-3, Anti-cyclic citrullinated peptide antibody, Rheumatoid factor, Rheumatoid arthritis